Special access opens for patients with muscle loss and obesity

This program provides access to an experimental treatment for people with sarcopenic obesity (low muscle mass combined with excess body fat) who cannot participate in regular clinical trials. It's designed for patients who meet specific criteria for both obesity and muscle weakness, but who live too far from trial sites or don't qualify for other studies. The goal is to help manage this condition by offering treatment outside of standard clinical trial settings.